期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

评价疫苗保护性的病毒中和试验 被引量：4

下载PDF
导出
作者 查锦芬 肖长义
机构地区 三峡大学医学院科研科
出处 《广东医学》 CAS CSCD 北大核心 2008年第9期1587-1589,共3页 Guangdong Medical Journal
基金 国家自然科学基金资助项目(编号:307770104) 湖北省教育厅重大课题(编号:Z200713002) 湖北省卫生厅科研基金资助项目(编号:JX3B32)
关键词 注射疫苗 中和试验 病毒 保护性 细胞水平 后血清 保护效果 中和抗体
分类号 R186 [医药卫生—流行病学] R512.99 [医药卫生—内科学]
  • 相关文献

参考文献15

  • 1WANG S, SAKHATSKYY P, CHOU T H, et al. Assays for the assessment of neutralizing antibody activities against Severe Acute Respiratory Syndrome ( SARS ) associated coronavirus ( SCV )[J].J Immunol Methods, 2005, 301(1 -2) : 21 -30.
  • 2BORGES M B, KATO S E, DAMASO C R, et al. Accuracy and repeatability of a micro plaque reduction neutralization test for vaccinia antibodies[J]. Biologicals, 2008, 36(2): 105-110.
  • 3ZIELINSKA E, LIU D, WU H Y, et al. Development of an improved microneutralization assay for respiratory syncytial virus by automated plaque counting using imaging analysis [ J]. Virol J, 2005, (2) : 84 - 89,
  • 4VENE S, HAGLUND M, LUNDKVIST A, et al. Study of the serological response after vaccination against tick - borne encephalitis in Sweden[J]. Vaccine, 2007, 25(2): 366-372.
  • 5KHAWPLOD P, INOUE K, SHOJI Y, et al. A novel rapid fluorescent focus inhibition test for rabies virus using a recombinant rabies virus visualizing a green fluorescent protein[ J]. J Virol Methods, 2005, 125(1): 35-40.
  • 6BAHLOUL C, TAIEB D, KAABI B, et al. Comparative evaluation of specific ELISA and RFFIT antibody assays in the assessment of dog immunity against rabies[J].Epidemiol Infect, 2005, 133(4) : 749 -757.
  • 7WANG Z, MO C, KEMBLE G, et al. Development of an efficient fluorescence - based microneutralization assay using recombinant human cytomegalovirus strains expressing green fluorescent protein [J]. J Virol Methods, 2004, 120(2) : 207 -215.
  • 8EARL P L, AMERICO J L, MOSS B, et al. Development and use of a vaccinia virus neutralization assay based on flow cytometric detection of green fluorescent protein [ J ]. J Virol, 2003, 77 ( 19 ) :10 684 - 10 688.
  • 9CHENG X, MUNOZ M G, ZHOU H, et al. Expression of beta - galactosidase by recombinant respiratory syncytial viruses for microneutralization assay[ J]. J Virol Methods, 2002, 105 (2) : 287 - 296.
  • 10宋建明,孙向乐,王一理,刘天菊,司履生.一种直接评价HPV16L1抗体活性的新方法[J].中国免疫学杂志,2002,18(3):169-171. 被引量：3

二级参考文献28

  • 1Bosh F X,Manos M M,Munoz N etal.Prevalence of human papillomavirus in cervcal cancer:a worldwide perspective[J].J NatlCancer Inst,1995;87:796
  • 2Sun X L,Si L S,Cao Z S et al.Immune response to plasmid DNA encoding HPV16-L1protein[J].Chinese Medicine Journal,2000;113(3):277
  • 3Murakami M,Gurski K J,Steller M A.Human papillomavirus vaccines for cervicalcancer[J].Ann Med,1999;31:51
  • 4Donnelly J J,Mertinez D,Jansen K Uet al.Protection against papillomavirus with apolynucleotide vaccine[J].J Infectious Diseases,1996;71:314
  • 5Christensen N D,Kreider J W,Cladel N M et al.Monoclonal antibody-mediatedneutralization of infectious human papillomavirus type 11[J].J Virol,1990;64:5678
  • 6White W I,Wilson S D,Bonnez W et al.In vitro infection and type-restrictedantibody-mediated neutralization of authentic human papillomavirus type 16[J].BiomedPharmacother,1994;51:268
  • 7Roden R B S,Hubbert N L,Kirnbauer R et al.Papillomavirus L1 capsids agglutinatemouse erythrocytes through a proteinaceous receptor[J].J Virol,1995;69:5147
  • 8Vikoers C,Unckell F,Schirmacher P et al.Binding and internalization of humanpapillomavirus type 33 virus-like particles by eukaryotic cells[J].J Virol,1995;69:3258
  • 9Muller M,Gissmann L,Cristiano R J et al.Papillomavirus capsid binding and uptake bycells from different tissues and species[J].J Virol,1995;69:948
  • 10Munoz N, Bosch FX, Castellsague X et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective, lnt J Cancer, 2004, 111(2):278 - 285

共引文献14

同被引文献42

  • 1蒋虹,时建东,吴小闲.猫病毒血清学检测方法的建立及初步应用[J].中国实验动物学杂志,1999,9(1):39-41. 被引量：11
  • 2宋刚,干信.甘露聚糖肽生物活性的研究进展[J].化学与生物工程,2007,24(4):14-16. 被引量：43
  • 3Wang SM, Ho TS, Lin HC, et al. Reemerging of enterovirus 71 in Taiwan:the age impact on disease severity [ J ]. Eur J Clin Microbiol Infect Dis, 2012,31:1219 - 1224.
  • 4Zhu FC, Wang H, Fang HH, et al. A novel influenze A ( H1N1 )vaccine in various age groups[ J]. N Engl J Med, 2009,361:2412 - 2423.
  • 5Prokesova L, Mlckova P, Stankova I, et al. Immunostimula- tory effect of bacillus firmus on mouse lymphocytes[ J ]. Fo- lia Microbiol,2002,47 : 193 - 197.
  • 6Wu D, Ke CW, Li W, et al. A large outbreak of hand, foot, and mouth disease caused by EV71 and CAV16 in Guang-dong,China,2009 [ J]. Orifinal Article arch virol, 2011, 156 : 945 - 953.
  • 7Chan LG, Parashar UD, Lye MS, et al. Deaths of children during an outbreak of hand,foot,and mouth disease in Sara- wak, malaysia: clinical and pathological characteristics of the disease[ J]. Clin Infeet Dis,2000,31:678 - 683.
  • 8Hognesch H. Mechanisms of stimulation of the immune re- sponseby aluminum adjuvants [ J ]. Vaccine, 2002, 20 : 34 - 39.
  • 9Duclos P. Safety of immunization and adverse events fol- lowing vaccination against hepatitis B [ J ]. Expert Opinion on Drug Safe,2003,2:225 - 231.
  • 10Lamm ME. Interactions of antigens and antibodies at muco- sal surfaces [ J ]. Annu Rer Microbilo, 1997,51:311 - 340.

引证文献4

二级引证文献6

广东医学
2008年 第9期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部